Bolt Biotherapeutics, Inc.
BOLT$7M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaREDWOOD CITY40 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
May 2027
Market Overview
Stock performance and key metrics
BOLT News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
BDC-4182 | Phase 2 | Gastric Cancer Adenocarcinoma Metastatic | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply